TLIS
Talis Biomedical Corporation Common Stock
TLIS
TLIS
Delisted
TLIS was delisted on the 30th of August, 2024.
35 hedge funds and large institutions have $12.1M invested in Talis Biomedical Corporation Common Stock in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 17 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
35
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$300K | |
| 2 | +$213K | |
| 3 | +$96.1K | |
| 4 |
E
Ergoteles
New York
|
+$73.2K |
| 5 |
Mercer Global Advisors
Denver,
Colorado
|
+$72.2K |
Top Sellers
| 1 | -$965K | |
| 2 | -$757K | |
| 3 | -$212K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$127K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$101K |